Capstone Investment Advisors, LLC Abbott Laboratories Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

A detailed history of Capstone Investment Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 223,000 shares of ABT stock, worth $25.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

223,000

Previous 58,061 284.08%

Holding current value

$25.6 Million

Previous $6.03 Million 321.42%

% of portfolio

0.08%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $5.76 Million - $6.8 Million	-57,532 Reduced 99.09%	529 $60,000
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $4.74 Million - $5.29 Million	47,052 Added 427.4%	58,061 $6.03 Million
Q1 2024 May 01, 2024	BUY	$109.52 - $120.96 $1.06 Million - $1.17 Million	9,643 Added 705.93%	11,009 $1.25 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $1.53 Million - $1.87 Million	-16,959 Reduced 92.55%	1,366 $150,000
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $1.56 Million - $1.87 Million	16,356 Added 830.68%	18,325 $1.77 Million
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $2.03 Million - $2.27 Million	-20,174 Reduced 91.11%	1,969 $214,000
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $8.43 Million - $9.92 Million	-87,031 Reduced 79.72%	22,143 $2.24 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $3.23 Million - $3.78 Million	-33,936 Reduced 23.71%	109,174 $12 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $8.56 Million - $9.91 Million	88,465 Added 161.89%	143,110 $13.8 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $4.93 Million - $5.96 Million	-48,308 Reduced 46.92%	54,645 $5.94 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $11.7 Million - $14.3 Million	102,840 Added 91008.85%	102,953 $12.2 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $8.32 Million - $10.2 Million	-71,983 Reduced 99.84%	113 $16,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $2.88 Million - $3.19 Million	24,681 Added 52.05%	72,096 $8.52 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $3.89 Million - $4.58 Million	36,812 Added 347.18%	47,415 $5.5 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $277,768 - $309,221	3,538 Added 50.08%	10,603 $921,000
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $290,613 - $315,115	-3,551 Reduced 33.45%	7,065 $591,000
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $551,847 - $643,620	7,572 Added 248.75%	10,616 $893,000
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $722,062 - $872,974	-10,904 Reduced 78.18%	3,044 $243,000
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $802,986 - $886,255	13,948 New	13,948 $851,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account

Capstone Investment Advisors, LLC Abbott Laboratories Transaction History